Beyond generic testing
Elizabeth Stotland Weiswasser examines the status of the statutory safe harbor
exemption from pharmaceutical companies in the US, in light of the Federal Circuit's
comments in the recent Integra case
The goal of the US patent system, rooted in the Constitution, is
to "promote the progress of science and useful arts". To further
this goal, the patent system provides inventors with exclusive
rights to their discoveries for a defined period in exchange for
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.